Chemours Completes Sale of Clean and Disinfect Business to LANXESS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Jefferies Raises Price Target on Chemours (CC) to $15; Reiterates Hold
September 1, 2016 9:05 AM EDTJefferies reiterated a Hold rating on Chemours (NYSE: CC), and raised the price target to $15.00 (from $10.00), after adjusting estimates for tailwinds. Jefferies raised 2016 estimates $0.15 to $0.80, 2017 $0.40 to $1.35, and 2018 $0.35 to $1.90.
Analyst Laurence Alexander commented, "We are raising our estimates to better reflect tailwinds from... More
